Histaminergic neurons of the tuberomammillary nucleus (TMN neurons)

The histaminergic neurons of the tuberomammillary nucleus (TMN) are a distinct population of cells located in the posterior hypothalamus that serve as the sole source of neuronal histamine within the vertebrate central nervous system (Haas et al., 2008). These neurons project extensively to nearly all major brain regions, including the cortex, thalamus, and hippocampus, where they function to promote arousal, maintain wakefulness, and facilitate cognitive processes such as attention and memory (Panula & Nuutinen, 2013). Their activity is highly state-dependent, showing peak firing rates during wakefulness and becoming quiescent during both non-REM and REM sleep. In clinical pharmacology, these neurons are primarily modulated via the Histamine H3 receptor, a G protein-coupled receptor that acts as an autoreceptor to inhibit the synthesis and release of histamine (Passani & Blandina, 2011). Drugs such as pitolisant leverage this mechanism by acting as H3 receptor antagonists/inverse agonists to enhance histaminergic signaling, which is used to treat excessive daytime sleepiness in conditions like narcolepsy. Dysfunctional histaminergic signaling from the TMN is implicated in the pathophysiology of various neurological disorders, including Alzheimer's disease, where histaminergic tone is significantly reduced, and schizophrenia, where it may be dysregulated (Brown et al., 2001).

Other names

Tuberomammillary nucleus (TMN)Hypothalamic histaminergic neuronsPosterior hypothalamic histaminergic systemHistaminergic cell groups E1-E5

Pharmacological modulation typically occurs through the antagonism or inverse agonism of the Histamine H3 autoreceptor located on these neurons, which prevents the feedback inhibition of histamine release, thereby increasing histaminergic tone in the brain.